The struggle to make clinical trials easier to conduct and more attractive to patients while understanding the impact of ...

The agreement between BioNTech’s subsidiary BioNTech UK and the UK government is focused on accelerating clinical trials for ...

Olaparib tablets, marketed under the brand name Lynparza, are already available on the NHS for certain breast cancer ...

Science communication, together with creativity, ensures that information is both accurate and accessible. In order to ...

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and ...

Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.

AstraZeneca (AZ) has shared positive results from a phase 3b study of its anti-inflammatory reliever rescue therapy Airsupra ...

In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

VML France has announced the appointment of Philippe Huot-Louradour as director of VML Health France. Hout, who has also been ...

Merck & Co – known as MSD outside of the US and Canada – has announced that its Welireg (belzutifan) has been approved by the ...

Medscape Education is proud to announce the presentation of eight innovative educational research publications at the ...